Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission
Karan Seegobin,1 Muhamad Alhaj Moustafa,1 Liuyan Jiang,2 Han W Tun1 1Department of Hematology and Medical Oncology, Mayo Clinic Hospital, Jacksonville City, FL, 32224, USA; 2Department of Pathology, Mayo Clinic Hospital, Jacksonville City, FL, 32224, USACorrespondence: Karan SeegobinDepartment of He...
Guardado en:
Autores principales: | Seegobin K, Alhaj Moustafa M, Jiang L, Tun HW |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c325bbea53e476ca0f7d42ff524874f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
por: Ujjani C, et al.
Publicado: (2020) -
Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021) -
Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens
por: Zhang F, et al.
Publicado: (2019) -
Waldenström macroglobulinemia: biology, genetics, and therapy
por: Paludo J, et al.
Publicado: (2016) -
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
por: Schieber M, et al.
Publicado: (2019)